Fragile X Syndrome (FXS) is a genetic disorder that affects millions of people worldwide and is a leading cause of autism spectrum disorders. Researchers have identified a potential new treatment method for FXS, which involves contracting the CGG trinucleotide repeat in the FMR1 gene, thereby restoring the essential protein that is lacking in patients with FXS. The study found that the treatment resulted in improved behavior and cognitive abilities in mice models with FXS. While further trials and development are needed, this breakthrough could provide a promising new approach to treating FXS and other neurodevelopmental disorders.
Potential New Treatment Method for Fragile X Syndrome Identified
Researchers have identified a potential new treatment method for Fragile X Syndrome (FXS), a leading cause of autism spectrum disorders. The method involves contracting the CGG trinucleotide repeat in the FMR1 gene, thereby restoring the essential protein that is lacking in patients with FXS. The study found that the treatment resulted in improved behavior and cognitive abilities in mice models with FXS.
Latest from Blog
Manu Chopra, CEO of Karya Inc., emphasized the importance of utilizing artificial intelligence (AI) to reduce
Italy has decided to withdraw from China's Belt and Road Initiative, becoming the only G7 nation
Zerodha's top executives collectively received a remuneration of about ₹200 crore in the financial year 2022-23,
New research suggests that radiotherapy may not be necessary for many patients with ductal carcinoma in
The US Space Force's X-37B space plane is gearing up for its seventh mission, after landing
